Literature DB >> 8041115

On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes.

H Zhao1, Y L Boissy, Z Abdel-Malek, R A King, J J Nordlund, R E Boissy.   

Abstract

BACKGROUND: The Chediak-Higashi syndrome (CHS) is a disorder that affects the synthesis and/or maintenance of storage/secretory granules in various types of cells. Lysosomes of leukocytes and fibroblasts, dense bodies of platelets, azurophilic granules of neutrophils and melanosomes of melanocytes are generally larger in size and irregular in morphology, indicating that a common pathway in storage organellogenesis is affected in patients with CHS. EXPERIMENTAL
DESIGN: A pure line of melanocytes has been established using a 2 cm2 shave biopsy from a child with CHS. This 4-week-old male patient had oculocutaneous albinism and expressed neutropenia, impaired platelet function, and no natural killer cell activity. The cultured CHS melanocytes were analyzed for cell biological and biochemical aberrancies.
RESULTS: Cultured melanocytes demonstrated some large and/or complexed melanosomes that resembled those observed in melanocytes from ultrastructural sections of the biopsy. Cytoplasmic localization of tyrosinase, tyrosinase-related protein-1 and granulophysin (a 40 kilodalton membrane protein originally identified as a component in dense bodies of platelets) demonstrated a prominent perinuclear accumulation. The basal synthesis of melanin and the activity levels of tyrosine hydroxylase, dihydroxyphenylalanine (DOPA) oxidase, or DOPAchrome tautomerase were comparable to control Caucasian melanocytes in culture. However, melanin synthesis as well as the catalytic activities of tyrosinase were not dramatically upregulated in CHS melanocytes by the addition of isobutyl methylxanthine and cholera toxin in the growth medium when parameters were assayed in cell lysates. In contrast, when assays were performed using live cells, tyrosine hydroxylase demonstrated dramatic upregulation. Medium conditioned by CHS melanocytes demonstrated phenylthiourea-inhibitable tyrosinase activity. Melanocyte lysates and conditioned medium analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and DOPA staining showed an extra, approximately 100 kilodalton soluble protein band with DOPA positivity and tyrosinase immunoreactivity. In addition to tyrosinase, one of three lysosomal enzymes assayed (beta-glucuronidase) was aberrantly secreted into the medium.
CONCLUSIONS: These results demonstrate that melanocytes cultured from CHS express a defect in the structure and/or function of the melanosome and abnormal trafficking of some cellular proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041115

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  17 in total

1.  PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum.

Authors:  I C Le Poole; R E Boissy; R Sarangarajan; J Chen; J J Forristal; P Sheth; W Westerhof; G Babcock; P K Das; C B Saelinger
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

2.  Functions of adaptor protein (AP)-3 and AP-1 in tyrosinase sorting from endosomes to melanosomes.

Authors:  Alexander C Theos; Danièle Tenza; José A Martina; Ilse Hurbain; Andrew A Peden; Elena V Sviderskaya; Abigail Stewart; Margaret S Robinson; Dorothy C Bennett; Daniel F Cutler; Juan S Bonifacino; Michael S Marks; Graça Raposo
Journal:  Mol Biol Cell       Date:  2005-09-14       Impact factor: 4.138

3.  Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".

Authors:  R E Boissy; H Zhao; W S Oetting; L M Austin; S C Wildenberg; Y L Boissy; Y Zhao; R A Sturm; V J Hearing; R A King; J J Nordlund
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

Review 4.  Albinism: modern molecular diagnosis.

Authors:  S M Carden; R E Boissy; P J Schoettker; W V Good
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

5.  Cytolytic mechanisms involved in non-MHC-restricted cytotoxicity in Chediak-Higashi syndrome.

Authors:  T Nakazawa; K Agematsu; K Yasui; T Onodera; R Inoue; H Kaneko; N Kondo; M Yamamoto; N Kayagaki; H Yagita; K Okumura; A Komiyama
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

6.  Identification of mutations in two major mRNA isoforms of the Chediak-Higashi syndrome gene in human and mouse.

Authors:  M D Barbosa; F J Barrat; V T Tchernev; Q A Nguyen; V S Mishra; S D Colman; E Pastural; R Dufourcq-Lagelouse; A Fischer; R F Holcombe; M R Wallace; S J Brandt; G de Saint Basile; S F Kingsmore
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

7.  Identification of the homologous beige and Chediak-Higashi syndrome genes.

Authors:  M D Barbosa; Q A Nguyen; V T Tchernev; J A Ashley; J C Detter; S M Blaydes; S J Brandt; D Chotai; C Hodgman; R C Solari; M Lovett; S F Kingsmore
Journal:  Nature       Date:  1996-07-18       Impact factor: 49.962

8.  AP-3 mediates tyrosinase but not TRP-1 trafficking in human melanocytes.

Authors:  M Huizing; R Sarangarajan; E Strovel; Y Zhao; W A Gahl; R E Boissy
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

9.  Melanocyte-specific proteins are aberrantly trafficked in melanocytes of Hermansky-Pudlak syndrome-type 3.

Authors:  Raymond E Boissy; Bonnie Richmond; Marjan Huizing; Amanda Helip-Wooley; Yang Zhao; Amy Koshoffer; William A Gahl
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

10.  Elevated oxidative membrane damage associated with genetic modifiers of Lyst-mutant phenotypes.

Authors:  Colleen M Trantow; Adam Hedberg-Buenz; Sachiyo Iwashita; Steven A Moore; Michael G Anderson
Journal:  PLoS Genet       Date:  2010-07-01       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.